Form D Explorer

Thiogenesis Therapeutics, Corp. research brief

CIK 1877778

Generated Nov. 19, 2026, 7:55 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: TORONTO Ontario, Canada. Reported legal jurisdiction: ONTARIO, CANADA. These do not establish investor residence or where funds were deployed.

Reviewed offering links

Citation: Form D Explorer, “Thiogenesis Therapeutics, Corp. research brief,” CIK 1877778, retrieved Nov. 19, 2026, 7:55 a.m.. Cite the specific accessions used. No amounts have been summed.